{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69545da8cb029db7575279fc/69545e222305c7fb140afa41?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"“A tale of 2 Remdesivir trials” — Raytheon’s nuclear-tipped missiles. Unilever is an economic mirror. Gilead’s 2nd COVID trial.","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69545da8cb029db7575279fc/675709d09c4017cd619d9825b30ed3d2.jpeg?height=200","description":"Ben & Jerry’s owner Unilever announced earnings that reflect the product hoarding and usage habits of the entire world (we know you’re not showering). Raytheon snags a nuclear-tipped stealth cruise missile deal that reveals what the defense industry is facing in a corona-conomy. And Gilead’s COVID-19 treatment just had disappointing results from a leaked report — markets react accordingly.\nLearn more about your ad choices. Visit podcastchoices.com/adchoices","author_name":"Nick & Jack Studios"}